TORL-5-700

· TORL Biotherapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TORL-5-700, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma [Phase 1, Phase 2]